# AI DDDD 360 — LangGraph Orchestration Design Specification

## 1. Purpose

This specification defines the controlled LangGraph orchestration architecture
for AI DDDD 360 before graph implementation or execution.

Step 11.2 is DESIGN ONLY.

No LLM execution, external network access, clinical recommendation,
therapeutic recommendation, or autonomous wet-lab decision is activated.

## 2. Architecture

The intended controlled orchestration boundary is:

START
  ->
StateGraph
  ->
Disease Biology Agent
  ->
Target Intelligence Agent
  ->
Multi-Omics & Bimodality Agent
  ->
Structure & Binding Agent
  ->
Efficacy & Translational Agent
  ->
ADMET & Safety Agent
  ->
Clinical Intelligence Agent
  ->
Biology Deficit Agent
  ->
END

Each scientific agent is reached through the validated LangChain adapter
boundary.

Conceptual execution boundary:

Scientific Agent
    ->
LangChainScientificAgentAdapter.invoke()
    ->
RunnableLambda
    ->
LangGraph Node
    ->
Shared Scientific State

## 3. State Contract

Required orchestration state fields:

[
  "project",
  "disease",
  "scientific_question",
  "evidence_records",
  "interpretations",
  "inferences",
  "hypotheses",
  "uncertainties",
  "conflicting_evidence",
  "unsupported_assumptions",
  "biology_deficits",
  "agent_outputs",
  "human_review_required",
  "execution_status"
]

The state must preserve:

- evidence records
- evidence levels E0-E7
- interpretations
- inferences
- hypotheses
- conflicting evidence
- uncertainties
- unsupported assumptions
- Biology Deficits
- agent outputs
- human-review requirement
- execution status

## 4. Agent Nodes

The graph contains exactly eight scientific agent nodes:

1. Disease Biology Agent — Disease-context foundation
2. Target Intelligence Agent — Target intelligence
3. Multi-Omics & Bimodality Agent — Multi-omics and bimodality
4. Structure & Binding Agent — Structure and binding
5. Efficacy & Translational Agent — Efficacy and translation
6. ADMET & Safety Agent — ADMET and safety
7. Clinical Intelligence Agent — Clinical intelligence
8. Biology Deficit Agent — Biology deficit and uncertainty

## 5. Scientific Safety

The graph must preserve the AI DDDD 360 evidence hierarchy.

E1 computational evidence must never be silently treated as equivalent
to E6 clinical-trial evidence.

Binding must not be treated as equivalent to efficacy.

Evidence, interpretation, inference, hypothesis, and demonstrated effect
must remain distinguishable.

Conflicting evidence and uncertainty must remain visible.

Biology Deficits must remain explicit rather than being silently resolved.

## 6. Human Oversight

Human review remains required.

The orchestration layer must not autonomously:

- make therapeutic decisions
- make clinical decisions
- authorize wet-lab experiments
- convert hypotheses into demonstrated effects
- bypass scientific evidence requirements

## 7. Execution Boundary

Step 11.2 activates none of the following:

- LLM execution
- external network access
- external API execution
- wet-lab execution
- therapeutic recommendation
- clinical recommendation
- autonomous experiment selection

## 8. Disease Validation

Architecture:

Disease-agnostic.

Current role-model validation:

Parkinson's Disease.

Alzheimer's validation:

Inactive and not part of the current role-model validation track.

## 9. Reproducibility

The eventual orchestration implementation must preserve:

- project version
- agent identity
- adapter provenance
- evidence provenance
- execution configuration
- execution records
- graph configuration
- deterministic controlled fixtures where applicable
- scientific traceability

## 10. Step 11.2 Boundary

This document defines the design only.

Graph compilation and controlled graph execution belong to subsequent
Step 11 substeps.

No validated Step 9 or Step 10 implementation is modified by this step.

## 11. LangGraph Compatibility

Validated environment:

- Python 3.13.15
- LangChain 1.4.0
- LangGraph 1.2.11
- StateGraph available
- START available
- END available

